Terms: = Leukemia AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB
278 results:
1. Efficacy of Venetoclax and Azacitidine in Acute Myeloid leukemia Compared to Azacitidine Monotherapy: Real-World Experience.
Baba Y; Hida N; Sambe T; Abe M; Kabasawa N; Sakai H; Yoshimura K; Fukuda T
Anticancer Res; 2024 May; 44(5):2003-2007. PubMed ID: 38677735
[TBL] [Abstract] [Full Text] [Related]
2. Differential prognostic values of the three AKT isoforms in acute myeloid leukemia.
Corre E; Soum C; Pfeifer R; Bessière C; Dailhau S; Marbœuf C; Meggetto F; Touriol C; Récher C; Bousquet M; Pyronnet S
Sci Rep; 2024 Mar; 14(1):7070. PubMed ID: 38528080
[TBL] [Abstract] [Full Text] [Related]
3. Effectiveness of leukapheresis on early survival in acute myeloid leukemia: An observational propensity score matching cohort study.
Lee H; Han JH; Kim JK; Yoo J; Cho HS; Yoon JH; Cho BS; Kim HJ; Lim J; Jekarl DW; Kim Y
J Clin Apher; 2023 Dec; 38(6):727-737. PubMed ID: 37786990
[TBL] [Abstract] [Full Text] [Related]
4. Body mass trajectory from diagnosis to the end of treatment in a pediatric acute lymphoblastic leukemia cohort.
Galati PC; Rocha PRS; Gruezo ND; Amato AA
Sci Rep; 2023 Aug; 13(1):13590. PubMed ID: 37604919
[TBL] [Abstract] [Full Text] [Related]
5. [Analysis of
Cui M; Li QY; Lu XZ; Chao HY; Cai XH; Liu J; Hua HY; Wu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1019-1025. PubMed ID: 37551471
[TBL] [Abstract] [Full Text] [Related]
6. Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir.
Orofino G; Xue E; Doglio M; Noviello M; Tassi E; Cristante M; Acerbis A; Clerici D; Farina F; Campodonico E; Bruno A; Piemontese S; Mastaglio S; Diral E; Milani R; Ruggeri A; Corti C; Vago L; Bonini C; Peccatori J; Ciceri F; Lupo Stanghellini MT; Greco R
Bone Marrow Transplant; 2023 Oct; 58(10):1104-1111. PubMed ID: 37468541
[TBL] [Abstract] [Full Text] [Related]
7. Cytogenetic Characteristics of de novo Acute Myeloid leukemia in Southern Vietnam.
Thao LTT; Ha CT; Ha NTT; Beaupha SMC; Nghia H; Tung TT; Son NT; Binh NT; Dung PC; Vu HA; Xinh PT
Asian Pac J Cancer Prev; 2023 May; 24(5):1789-1795. PubMed ID: 37247302
[TBL] [Abstract] [Full Text] [Related]
8. Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients.
Noviello M; Lorentino F; Xue E; Racca S; Furnari G; Valtolina V; Campodonico E; Dvir R; Lupo-Stanghellini MT; Giglio F; Piemontese S; Clerici D; Oltolini C; Tassi E; Beretta V; Farina F; Mannina D; Ardemagni A; Vago L; Bernardi M; Corti C; Peccatori J; Clementi M; Ciceri F; Bonini C; Greco R
Blood Adv; 2023 Sep; 7(18):5446-5457. PubMed ID: 37067947
[TBL] [Abstract] [Full Text] [Related]
9. Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders.
Mikulska M; Testi D; Russo C; Balletto E; Sepulcri C; Bussini L; Dentone C; Magne F; Policarpo S; Campoli C; Miselli F; Cilli A; Ghiggi C; Aquino S; Di Grazia C; Giannella M; Giacobbe DR; Vena A; Raiola AM; Bonifazi F; Zinzani P; Cavo M; Lemoli R; Angelucci E; Viale P; Bassetti M; Bartoletti M
Br J Haematol; 2023 May; 201(4):628-639. PubMed ID: 36806152
[TBL] [Abstract] [Full Text] [Related]
10. Measuring what gets done: Using goal attainment scaling in a vocational counseling program for survivors of childhood cancer.
Pole JD; Williams B; Di Giuseppe G; Guger S; Stasiulis E; Greenberg ML; Spiegler BJ; Edelstein K
Cancer Med; 2023 Apr; 12(7):8676-8689. PubMed ID: 36775957
[TBL] [Abstract] [Full Text] [Related]
11. Hyperglycemia and Other Glycemic Measures Throughout Therapy for Pediatric Acute Lymphoblastic leukemia and Lymphoma.
Demedis J; Scarbro S; Suresh K; Maloney K; Forlenza GP
J Pediatr Hematol Oncol; 2023 Mar; 45(2):e154-e160. PubMed ID: 36715999
[TBL] [Abstract] [Full Text] [Related]
12. Clinical features of febrile neutropenia and bloodstream infection in autologous hematopoietic cell transplantation: Comparison to those in intensive chemotherapy for acute myeloid leukemia.
Yoshino N; Kimura SI; Matsuoka A; Meno T; Ishikawa T; Nakamura Y; Kawamura M; Takeshita J; Kawamura S; Misaki Y; Yoshimura K; Gomyo A; Okada Y; Tamaki M; Akahoshi Y; Kusuda M; Kameda K; Tanihara A; Wada H; Nakasone H; Kako S; Kanda Y
J Infect Chemother; 2023 Apr; 29(4):384-390. PubMed ID: 36669687
[TBL] [Abstract] [Full Text] [Related]
13. Alcoholic liver disease in relation to cancer incidence and mortality: Findings from a large, matched cohort study in South Korea.
Tran TPT; Han M; Luu NM; Oh JK
Cancer Med; 2023 Apr; 12(7):8754-8766. PubMed ID: 36653955
[TBL] [Abstract] [Full Text] [Related]
14. Common and rare variant associations with clonal haematopoiesis phenotypes.
Kessler MD; Damask A; O'Keeffe S; Banerjee N; Li D; Watanabe K; Marketta A; Van Meter M; Semrau S; Horowitz J; Tang J; Kosmicki JA; Rajagopal VM; Zou Y; Houvras Y; Ghosh A; Gillies C; Mbatchou J; White RR; Verweij N; Bovijn J; Parikshak NN; LeBlanc MG; Jones M; ; ; Glass DJ; Lotta LA; Cantor MN; Atwal GS; Locke AE; Ferreira MAR; Deering R; Paulding C; Shuldiner AR; Thurston G; Ferrando AA; Salerno W; Reid JG; Overton JD; Marchini J; Kang HM; Baras A; Abecasis GR; Jorgenson E
Nature; 2022 Dec; 612(7939):301-309. PubMed ID: 36450978
[TBL] [Abstract] [Full Text] [Related]
15. Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial.
Hillmen P; Eichhorst B; Brown JR; Lamanna N; O'Brien SM; Tam CS; Qiu L; Kazmierczak M; Zhou K; Šimkovič M; Mayer J; Gillespie-Twardy A; Shadman M; Ferrajoli A; Ganly PS; Weinkove R; Grosicki S; Mital A; Robak T; Österborg A; Yimer HA; Salmi T; Ji M; Yecies J; Idoine A; Wu K; Huang J; Jurczak W
J Clin Oncol; 2023 Feb; 41(5):1035-1045. PubMed ID: 36395435
[TBL] [Abstract] [Full Text] [Related]
16. Contemporary outcomes in IDH-mutated acute myeloid leukemia: The impact of co-occurring NPM1 mutations and venetoclax-based treatment.
Lachowiez CA; Reville PK; Kantarjian H; Jabbour E; Borthakur G; Daver N; Issa G; Furudate K; Tanaka T; Pierce S; Tang G; Patel KP; Medeiros J; Abbas HA; Haddad F; Hammond D; Short NJ; Maiti A; Yilmaz M; Sasaki K; Takahashi K; Pemmaraju N; Konopleva M; Garcia-Manero G; Ravandi F; Kadia TM; Loghavi S; DiNardo CD
Am J Hematol; 2022 Nov; 97(11):1443-1452. PubMed ID: 36054614
[TBL] [Abstract] [Full Text] [Related]
17. Charcoal burning is associated with a higher risk of delayed neurological sequelae after domestic carbon monoxide poisoning in South China: A retrospective cohort study.
Liu S; Liu Y; Yang C; Xie D; Zhang X
Am J Emerg Med; 2022 Oct; 60():57-61. PubMed ID: 35907270
[TBL] [Abstract] [Full Text] [Related]
18. Analysis of microRNA expression profiles in exosomes derived from acute myeloid leukemia by p62 knockdown and effect on angiogenesis.
Li C; Long X; Liang P; Liu Z; Wang C; Hu R
PeerJ; 2022; 10():e13498. PubMed ID: 35898936
[TBL] [Abstract] [Full Text] [Related]
19. Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT).
Maffini E; Labopin M; Beelen DW; Kroeger N; Arat M; Wilson KMO; Bay JO; Ganser A; Martin H; Passweg J; Kottaridis PD; Yakoub-Agha I; Porras RP; Wagner EM; Esteve J; Lanza F; Nagler A; Mohty M
Bone Marrow Transplant; 2022 Oct; 57(10):1556-1563. PubMed ID: 35835997
[TBL] [Abstract] [Full Text] [Related]
20. Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial.
Kater AP; Levin MD; Dubois J; Kersting S; Enggaard L; Veldhuis GJ; Mous R; Mellink CHM; van der Kevie-Kersemaekers AF; Dobber JA; Poulsen CB; Frederiksen H; Janssens A; Schjødt I; Dompeling EC; Ranti J; Brieghel C; Mattsson M; Bellido M; Tran HTT; Nasserinejad K; Niemann CU
Lancet Oncol; 2022 Jun; 23(6):818-828. PubMed ID: 35654052
[TBL] [Abstract] [Full Text] [Related]
[Next]
